ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue

March 29, 2013

Oxford Univ. Receives Funds To Create Drug Design Center.

October 6, 2000

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

$3.3 Million For Retinoid Contract Awarded

October 14, 1977

Cancer Control Seeks Grant Applications In Three Interventions Areas And In Community Development

September 13, 1974

NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants

February 14, 1992